MAPK3 and glioblastoma: This combinatorial approach not only underlines the involvement of the ERK1/2 signaling cascade in the mechanism of drug resistance in GBM but also allows for a reduction in the relative drugs’ concentration to efficiently increase GSCs sensitivity to TMZ.